Positions

Overview

  • Dr. Wood joined UAB Urology in July 2016. He completed his undergraduate degree at Brown University, graduating with honors. He then attended medical school at University of Massachusetts, and completed his residency at Wake Forest University. Dr. Wood is fellowship trained in endourology with a primary focus on kidney stone disease.

    His surgical expertise is in complex kidney stone disease and surgeries. He is a trained open, endoscopic, laparoscopic and robotic surgeon. Dr. Wood and nephrology have one of the only multidisciplinary metabolic kiney stone clinics in the Southeast. The focus of this clinic is on the workup of kidney stone formers and implementing dietary, medical and lifestyle modifications to prevent future kidney stones.

    He is an AUA research scholar and is conducting kidney stone research. His focus is on the metabolic pathways that lead to kidney stone disease, specifically evaluating the role of obesity in kidney stone disease. His research has basic, translational and clinical projects.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2020 Screening for primary hyperparathyroidism in a tertiary stone clinic, a useful endeavorInternational Urology and Nephrology.  52:1651-1655. 2020
    2020 Future treatments for hyperoxaluriaCurrent Opinion in Urology.  30:171-176. 2020
    2020 The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria 2020
    2019 Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity 2019
    2019 Dietary oxalate and kidney stone formation 2019
    2019 An Intervention to Increase 24-Hour Urine Collection ComplianceUrology Practice.  6:29-33. 2019
    2018 The influence of metabolic syndrome and its components on the development of nephrolithiasisAsian Journal of Urology.  5:215-222. 2018
    2017 Zero-fragment Nephrolithotomy: A Multi-center Evaluation of Robotic Pyelolithotomy and Nephrolithotomy for Treating Renal StonesEuropean Urology.  72:1014-1021. 2017
    2016 RNA interference in the treatment of renal stone disease: Current status and future potentialsInternational Journal of Surgery.  36:713-716. 2016
    2016 Evaluation of Renal Function after Percutaneous Nephrolithotomy—Does the Number of Percutaneous Access Tracts Matter? 2016
    2016 Oxalate formation from glyoxal in erythrocytesUrology.  88:226.e11-226.e15. 2016
    2013 Changing stone composition profile of children with nephrolithiasisUrology.  82:210-213. 2013
    2012 Sensitivity of human strains of oxalobacter formigenes to commonly prescribed antibioticsUrology.  79:1286-1289. 2012
    2012 The impact of dietary calcium and oxalate ratios on stone riskUrology.  79:1226-1229. 2012
    2012 Glyoxal formation and its role in endogenous oxalate synthesisAdvances in Urology2012
    2012 The association of cardiovascular disease and metabolic syndrome with nephrolithiasisCurrent Opinion in Urology.  22:154-159. 2012
    2011 Re: Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers 2011
    2011 Oxalate and sucralose absorption in idiopathic calcium oxalate stone formersUrology.  78:475.e9-475.e13. 2011

    Education And Training

    Full Name

  • Kyle Wood